{
  "ptid_time": "020_S_4920_2012-12-15",
  "img_path": "/data/qiuhui/data/adni/images/020_S_4920/2012-12-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 23,796 mm³, 20.7% below the reference mean. With a Z-score of -0.49 (31.1th percentile), this represents normal volume ; hippocampal volume measures 7,257 mm³, 9.6% below the reference mean. With a Z-score of -0.96 (16.9th percentile), this represents normal volume ; whole brain volume measures 1,127,310 mm³, 0.6% below the reference mean. With a Z-score of -0.09 (46.4th percentile), this represents normal volume ; entorhinal cortex volume measures 2,932 mm³, 31.2% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 19,719 mm³, 1.0% below the reference mean. With a Z-score of -0.08 (46.8th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,143 mm³, 5.7% below the reference mean. With a Z-score of -0.47 (32.1th percentile), this represents normal volume . ",
  "text_data": "Age is 61.9 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Endocrine-Metabolic. MMSE: 28.0. MoCA: 25.0. Logical Memory: 5.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.35 SUVR (significant elevated); Amyloid beta: 597.70 pg/mL (mild reduced); Total tau: 207.30 pg/mL (normal ); Phosphorylated tau: 19.81 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The entorhinal cortex shows significant atrophy (Z-score -2.16, 1.5th percentile), which is a strong early marker of Alzheimer's pathology. Other brain regions are within normal limits, and cognitive scores (MMSE 28, MoCA 25) are borderline normal/mildly impaired. Elevated AV45 (amyloid PET) and mild Aβ reduction in CSF suggest amyloid pathology, while normal tau levels argue against advanced neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (due to borderline cognitive scores and isolated entorhinal atrophy, but strong biomarker support for early Alzheimer's changes)  \n\n*Note: APOE4 homozygosity (2 alleles) increases Alzheimer's risk, reinforcing the likelihood of prodromal AD.*",
  "timestamp": "2025-07-26T01:14:00.481341"
}